Fresenius Medical Care AG
FMS· NYSE
FMSFresenius Medical Care AG
Quarterly figures for Fresenius Medical Care AG, with source filings when available.
36 quarters. Mar 31, 2017 to Dec 31, 2025. EUR.
Filing lag not yet established. Fewer than two comparable filings are on file.
Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | — | — | — | €5.07B | −0.3% | — | |
| Q3 2025 | Sep 30, 2025 | — | — | — | — | €4.88B | +2.6% | €0.94 | |
| Q2 2025 | Jun 30, 2025 | — | — | — | — | €4.79B | +0.5% | €0.77 | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | €4.88B | +3.3% | €0.52 | |
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | — | — | — | €5.08B | +1.9% | — | |
| Q3 2024 | Sep 30, 2024 | — | — | — | — | €4.76B | −3.6% | €0.73 | |
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | — | — | — | €4.99B | −0.2% | — | |
| Q3 2023 | Sep 30, 2023 | — | — | — | — | €4.94B | −3.1% | €0.29 | |
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | — | — | — | €5.00B | +7.5% | — | |
| Q3 2022 | Sep 30, 2022 | — | — | — | — | €5.10B | +14.7% | €0.78 | |
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | — | — | — | €4.65B | +5.6% | — | |
| Q3 2021 | Sep 30, 2021 | — | — | — | — | €4.44B | +0.6% | €0.93 | |
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | €4.40B | −3.9% | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | €4.41B | −0.1% | €1.21 | |
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | €4.58B | +6.5% | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | €4.42B | +8.9% | €1.10 | |
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | — | — | — | €4.30B | −2.9% | — | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | €4.06B | −6.4% | €0.93 | |
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | — | — | — | €4.43B | — | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | €4.34B | — | €1.01 | |
| Q2 2024 |
|---|
| Jun 30, 2024 |
| — |
| — |
| — |
| — |
| €4.77B |
| −1.2% |
| €0.64 |
| Q1 2024 | Mar 31, 2024 | — | — | — | — | €4.72B | +0.4% | €0.24 |
|---|
| Q2 2023 |
|---|
| Jun 30, 2023 |
| — |
| — |
| — |
| — |
| €4.83B |
| +1.4% |
| €0.48 |
| Q1 2023 | Mar 31, 2023 | — | — | — | — | €4.70B | +3.4% | €0.29 |
|---|
| Q2 2022 |
|---|
| Jun 30, 2022 |
| — |
| — |
| — |
| — |
| €4.76B |
| +10.1% |
| €0.50 |
| Q1 2022 | Mar 31, 2022 | — | — | — | — | €4.55B | +8.0% | €0.54 |
|---|
| Q2 2021 |
|---|
| Jun 30, 2021 |
| — |
| — |
| — |
| — |
| €4.32B |
| −5.2% |
| €0.75 |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | €4.21B | −6.2% | €0.85 |
|---|
| Q2 2020 |
|---|
| Jun 30, 2020 |
| — |
| — |
| — |
| — |
| €4.56B |
| +4.9% |
| €1.20 |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | €4.49B | +8.6% | €0.95 |
|---|
| Q2 2019 |
|---|
| Jun 30, 2019 |
| — |
| — |
| — |
| — |
| €4.35B |
| +3.1% |
| €0.84 |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | €4.13B | +3.9% | €0.88 |
|---|
| Q2 2018 |
|---|
| Jun 30, 2018 |
| — |
| — |
| — |
| — |
| €4.21B |
| −5.8% |
| €3.23 |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | €3.98B | −12.6% | €0.91 |
|---|
| Q2 2017 |
|---|
| Jun 30, 2017 |
| — |
| — |
| — |
| — |
| €4.47B |
| — |
| €0.87 |
| Q1 2017 | Mar 31, 2017 | — | — | — | — | €4.55B | — | €1.00 |
|---|
